Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine.

Gu Y, Walker C, Ryan ME, Payne JB, Golub LM.

J Oral Microbiol. 2012;4. doi: 10.3402/jom.v4i0.19227. Epub 2012 Oct 12.

PMID:
23071896
[PubMed]
Free PMC Article
2.

Introduction and background.

Golub LM.

Pharmacol Res. 2011 Feb;63(2):99-101. doi: 10.1016/j.phrs.2010.10.003. Epub 2010 Oct 16.

PMID:
20937387
[PubMed - indexed for MEDLINE]
3.

Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug.

Lee HM, Ciancio SG, Tüter G, Ryan ME, Komaroff E, Golub LM.

J Periodontol. 2004 Mar;75(3):453-63.

PMID:
15088884
[PubMed - indexed for MEDLINE]
4.

Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation.

Gu Y, Lee HM, Sorsa T, Salminen A, Ryan ME, Slepian MJ, Golub LM.

Pharmacol Res. 2011 Dec;64(6):573-9. doi: 10.1016/j.phrs.2011.06.023. Epub 2011 Jul 13. Review.

PMID:
21771657
[PubMed - indexed for MEDLINE]
5.

Clinical applications of non-antimicrobial tetracyclines in dermatology.

Monk E, Shalita A, Siegel DM.

Pharmacol Res. 2011 Feb;63(2):130-45. doi: 10.1016/j.phrs.2010.10.007. Epub 2010 Oct 19. Review.

PMID:
20937386
[PubMed - indexed for MEDLINE]
6.

Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents. A systematic review.

Reddy MS, Geurs NC, Gunsolley JC.

Ann Periodontol. 2003 Dec;8(1):12-37. Review.

PMID:
14971246
[PubMed - indexed for MEDLINE]
7.

Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.

Ramamurthy NS, Rifkin BR, Greenwald RA, Xu JW, Liu Y, Turner G, Golub LM, Vernillo AT.

J Periodontol. 2002 Jul;73(7):726-34.

PMID:
12146531
[PubMed - indexed for MEDLINE]
8.

Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs.

Rifkin BR, Vernillo AT, Golub LM.

J Periodontol. 1993 Aug;64(8 Suppl):819-27. Review.

PMID:
8410621
[PubMed - indexed for MEDLINE]
9.

Chemically modified tetracycline-3 (CMT-3): a novel inhibitor of the serine proteinase, elastase.

Gu Y, Lee HM, Simon SR, Golub LM.

Pharmacol Res. 2011 Dec;64(6):595-601. doi: 10.1016/j.phrs.2011.05.011. Epub 2011 May 31. Review.

PMID:
21651982
[PubMed - indexed for MEDLINE]
10.

MMP-mediated events in diabetes.

Ryan ME, Ramamurthy NS, Sorsa T, Golub LM.

Ann N Y Acad Sci. 1999 Jun 30;878:311-34.

PMID:
10415738
[PubMed - indexed for MEDLINE]
11.

Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD).

Caton J, Ryan ME.

Pharmacol Res. 2011 Feb;63(2):114-20. doi: 10.1016/j.phrs.2010.12.003. Epub 2010 Dec 21. Review.

PMID:
21182947
[PubMed - indexed for MEDLINE]
12.

The nonantimicrobial properties of tetracycline for the treatment of periodontal disease.

Vernillo AT, Ramamurthy NS, Golub LM, Rifkin BR.

Curr Opin Periodontol. 1994:111-8. Review.

PMID:
8032451
[PubMed - indexed for MEDLINE]
13.

Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives.

Grenier D, Plamondon P, Sorsa T, Lee HM, McNamara T, Ramamurthy NS, Golub LM, Teronen O, Mayrand D.

J Periodontol. 2002 Jan;73(1):79-85.

PMID:
11846203
[PubMed - indexed for MEDLINE]
14.

Host modulation with tetracyclines and their chemically modified analogues.

Golub LM, Suomalainen K, Sorsa T.

Curr Opin Dent. 1992 Mar;2:80-90. Review.

PMID:
1325849
[PubMed - indexed for MEDLINE]
15.

Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model.

Lokeshwar BL, Selzer MG, Zhu BQ, Block NL, Golub LM.

Int J Cancer. 2002 Mar 10;98(2):297-309.

PMID:
11857423
[PubMed - indexed for MEDLINE]
16.

Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. A review.

Preshaw PM, Hefti AF, Jepsen S, Etienne D, Walker C, Bradshaw MH.

J Clin Periodontol. 2004 Sep;31(9):697-707. Review.

PMID:
15312090
[PubMed - indexed for MEDLINE]
17.

Tetracyclines and pulmonary inflammation.

Rempe S, Hayden JM, Robbins RA, Hoyt JC.

Endocr Metab Immune Disord Drug Targets. 2007 Dec;7(4):232-6. Review.

PMID:
18220943
[PubMed - indexed for MEDLINE]
18.

Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms.

Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T.

Adv Dent Res. 1998 Nov;12(2):12-26. Review.

PMID:
9972117
[PubMed - indexed for MEDLINE]
19.

Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity.

Ryan ME, Usman A, Ramamurthy NS, Golub LM, Greenwald RA.

Curr Med Chem. 2001 Feb;8(3):305-16.

PMID:
11172685
[PubMed - indexed for MEDLINE]
20.

Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes.

Uitto VJ, Firth JD, Nip L, Golub LM.

Ann N Y Acad Sci. 1994 Sep 6;732:140-51.

PMID:
7978787
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk